FIELD: medicine; pharmacology.
SUBSTANCE: agent contains Meloxicam as active substance, sodium chloride, glycine, glycofurol (tetraglycol), poloxamer (luthrol), methyl glucamine, sodium hydroxide and water for injection as additives. Glycofurol and poloxamer ratio is 2:1. New formulation of Meloxicam represented with intramuscular injected solution is produced.
EFFECT: higher efficiency of treatment of arthropathy accompanied with pain syndrome.
